Intravenous immunoglobulin treatment in neurological diseases.
作者信息
Otten A, Vermeulen M, Bossuyt P M, Otten A
出版信息
J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):359-61. doi: 10.1136/jnnp.60.4.359.
Abstract
摘要
相似文献
1
Intravenous immunoglobulin treatment in neurological diseases.
J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):359-61. doi: 10.1136/jnnp.60.4.359.
2
Pharmacoeconomics of intravenous immunoglobulin in various neurological disorders.
Acta Neurol Taiwan. 2010 Dec;19(4):303-8.
3
A practical approach to the use of intravenous immunoglobulin in neurological disease.
Eur Neurol. 1998;39(1):3-8. doi: 10.1159/000007891.
4
[Expert opinion on use of intravenous immunoglobulins in the management of neurological disorders].
Neurol Neurochir Pol. 2011 Nov-Dec;45(6):525-35. doi: 10.1016/s0028-3843(14)60119-5.
5
6
Intravenous immunoglobulin in neurological disorders: a mechanistic perspective.
J Neurol. 2005 May;252 Suppl 1:I1-6. doi: 10.1007/s00415-005-1102-7.
7
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
Eur J Neurol. 2008 Sep;15(9):893-908. doi: 10.1111/j.1468-1331.2008.02246.x.
8
Gammaglobulin Treatment in Neurology, Fundamentals and Clinical Applications. Proceedings of a symposium. Berlin, Germany, 25-27 November 1993.
J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):1-75.
9
[Use of immunoglobulin in the therapy of neurological illnesses].
Duodecim. 2001;117(10):1033-41; quiz 1041, 1081.
10
[Immunotherapy of intravenous immunoglobulin preparations in neurologic diseases].
Postepy Hig Med Dosw. 2002;56 Suppl:69-83.
引用本文的文献
1
Rare indications of IVIG therapy in neurological diseases based on case reports and small studies.
J Neurol. 2006 Sep;253 Suppl 5:V66-9. doi: 10.1007/s00415-006-5011-1.
本文引用的文献
1
Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin.
Neurology. 1993 May;43(5):876-9. doi: 10.1212/wnl.43.5.876.
2
Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases.
Vox Sang. 1993;64(2):65-72. doi: 10.1111/j.1423-0410.1993.tb02521.x.
3
Vigabatrin.
Ann Pharmacother. 1993 Feb;27(2):197-204. doi: 10.1177/106002809302700215.
4
Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
Pediatr Res. 1993 Jan;33(1 Suppl):S95-100. doi: 10.1203/00006450-199333011-00017.
5
Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study.
J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):36-9. doi: 10.1136/jnnp.56.1.36.
6
Immunosuppressive treatments. Their efficacy on myasthenia gravis patients' outcome and on the natural course of the disease.
Ann N Y Acad Sci. 1993 Jun 21;681:594-602. doi: 10.1111/j.1749-6632.1993.tb22951.x.
7
Myasthenic crisis. Response to plasmapheresis following failure of intravenous gamma-globulin.
Arch Neurol. 1993 Aug;50(8):837-40. doi: 10.1001/archneur.1993.00540080046012.
8
Indications for use of intravenous immunoglobulin. Recommendations of the Australasian Society of Blood Transfusion consensus symposium.
Med J Aust. 1993 Aug 2;159(3):204-6. doi: 10.5694/j.1326-5377.1993.tb137790.x.
9
A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
N Engl J Med. 1993 Dec 30;329(27):1993-2000. doi: 10.1056/NEJM199312303292704.
10
The role of vigabatrin in the management of infantile epileptic syndromes.
Neurology. 1993 Nov;43(11 Suppl 5):S21-3.
Zotero 插件